Temporal trends in prevalence and antithrombotic treatment among Asians with atrial fibrillation undergoing percutaneous coronary intervention: A nationwide Korean population-based study-Reference-Cited by-同舟云学术

Temporal trends in prevalence and antithrombotic treatment among Asians with atrial fibrillation undergoing percutaneous coronary intervention: A nationwide Korean population-based study

Published:2019-01-15 Issue:1 Volume:14 Page:e0209593
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Park Jiesuck,Choi Eue-Keun^ORCID,Han Kyung-Do,Choi You-jung,Lee Euijae,Choe Wonseok,Lee So-Ryoung,Cha Myung-Jin,Lim Woo-Hyun,Kang Jeehoon,Park Kyung Woo,Oh Seil,Lip Gregory Y. H.

Funder

Seoul National University Hospital Research Fund

Korea National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology

Korean Healthcare Technology R&D project funded by the Ministry of Health & Welfare

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference33 articles.

1. Trends in the incidence and prevalence of atrial fibrillation and estimated thromboembolic risk using the CHA2DS2-VASc score in the entire Korean population;SR Lee;Int J Cardiol,2017

2. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS;P Kirchhof;Eur J Cardiothorac Surg,2016

3. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society;CT January;Circulation,2014

4. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS);M Valgimigli;Eur Heart J,2018

5. Prevalence, management, and long-term (6-year) outcomes of atrial fibrillation among patients receiving drug-eluting coronary stents;HI Choi;JACC Cardiovasc Interv,2017

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative safety review of antithrombotic treatment options for patients with atrial fibrillation undergoing percutaneous coronary intervention;Expert Opinion on Drug Safety;2024-01-17

2. Antithrombotic Therapy Increases the Risk of Bleeding after Endoscopic Submucosal Dissection for Early Gastric Cancer: A Propensity Score-Matched Analysis;Cancers;2023-05-19

3. Utilization of triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention;European Journal of Clinical Pharmacology;2023-02-24

4. Evolution of and Evidence-Practice Gaps in Antithrombotic Management of Atrial Fibrillation Patients After Percutaneous Coronary Intervention;CJC Open;2023-01

5. The Optimal Duration and De-escalation Strategy of Antiplatelet Agents and Anticoagulation Agents in Korean Patients Undergoing Percutaneous Coronary Intervention;CardioMetabolic Syndrome Journal;2023